Page last updated: 2024-10-20

pyridoxine and Graft Occlusion, Vascular

pyridoxine has been researched along with Graft Occlusion, Vascular in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamura, T1
Bergman, SM1
Morgan, SL1

Other Studies

1 other study available for pyridoxine and Graft Occlusion, Vascular

ArticleYear
Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 32, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Erythrocytes

1998